Clinical Trial

Cefotetan Therapy for Escherichia Coli Infections

Name: Cefotetan Therapy for Escherichia Coli Infections — clinical trial record (NCT07318584)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This pilot study will compare clinical outcomes among patients treated with cefotetan versus standard of care antibiotics for bacteremia or genitourinary infections caused by E. coli. It will also measure cefotetan minimum inhibitory concentration (MIC) distributions and cefotetan trough serum concentrations.

Trial Details

NCT Number	NCT07318584
Lead Sponsor	Oregon Health and Science University
Conditions	E Coli Infection, ESBL Producing E.Coli
Enrollment	84 participants
Start Date	2026-03
Primary Completion	2028-02 (estimated)
Study Completion	2028-08 (estimated)
Updated on ClinicalTrials.gov	2026-01-06